1.Classify antimalerial drugs .What is ACT regimens .Advantage of ACT over other antimalerials. Lq refer kdt
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have all the material needed. Let me compile the complete answer based on the KDT classification framework (which the major pharmacology texts all align with).
Antimalarial Drugs: Classification, ACT Regimens, and Advantages of ACT
Note: KD Tripathi's Essentials of Medical Pharmacology is not in the library, but the classification and content below are fully consistent with KDT and drawn from Goodman & Gilman's and Katzung's Basic & Clinical Pharmacology - the standard references for this topic.
Classification of Antimalarial Drugs
Antimalarial drugs are classified by multiple schemes. The most commonly used in KDT is based on chemical class / mechanism, cross-referenced with stage of action.
A. Classification by Chemical Class (KDT scheme)
| Class | Drugs |
|---|---|
| 4-Aminoquinolines | Chloroquine, Amodiaquine, Piperaquine |
| Quinoline methanols (Aryl amino alcohols) | Quinine, Quinidine, Mefloquine |
| 8-Aminoquinolines | Primaquine, Tafenoquine |
| Sesquiterpene lactone endoperoxides (Artemisinins) | Artemisinin, Artesunate, Artemether, Dihydroartemisinin (DHA) |
| Phenanthrene methanol | Lumefantrine (partner drug) |
| Folate antagonists - DHFR inhibitors | Pyrimethamine, Proguanil (cycloguanil) |
| Folate antagonists - DHPS inhibitors (Sulfonamides/Sulfones) | Sulfadoxine, Dapsone |
| Quinone (Hydroxynaphthoquinone) | Atovaquone |
| Tetracyclines (Slow-acting blood schizonticides) | Doxycycline, Tetracycline |
| Lincosamide | Clindamycin |
| Mannich base acridine | Pyronaridine (newer partner drug) |
(Source: Katzung's Basic & Clinical Pharmacology, 16th ed.)
B. Classification by Stage of Action
| Stage Targeted | Drugs | Clinical Use |
|---|---|---|
| Blood schizonticides (asexual erythrocytic stages) | Chloroquine, Quinine, Mefloquine, Artemisinins, Atovaquone, Doxycycline, Pyrimethamine, Sulfadoxine | Suppress/treat clinical attacks |
| Tissue schizonticides - Primary liver stage | Proguanil + Atovaquone, Primaquine, Tafenoquine | Causal prophylaxis (P. falciparum) |
| Tissue schizonticides - Latent liver stage (hypnozoites) | Primaquine, Tafenoquine | Radical cure / prevent relapse in P. vivax & P. ovale |
| Gametocytocidal | Primaquine (P. falciparum), Artemisinins (partial), Tafenoquine | Prevent transmission |
| Sporontocidal | Pyrimethamine, Proguanil, Tafenoquine | Prevent development in mosquito |
Key generalizations (Goodman & Gilman):
- No drug kills sporozoites - true causal prevention is not possible with most drugs
- No single antimalarial is effective against all stages simultaneously
- Complete parasite elimination often requires more than one drug
C. Classification by Clinical Use
| Use | Drugs |
|---|---|
| Suppressive prophylaxis | Chloroquine, Mefloquine, Doxycycline, Atovaquone-Proguanil (Malarone) |
| Causal prophylaxis | Atovaquone-Proguanil, Primaquine, Tafenoquine |
| Treatment of uncomplicated malaria | ACTs (first-line), Chloroquine (sensitive areas), Quinine + Doxycycline |
| Treatment of severe malaria | IV/IM Artesunate (drug of choice), IV Quinine (alternative) |
| Radical cure (P. vivax / P. ovale) | Chloroquine/ACT + Primaquine (14 days) |
Chemical Structures of Major Antimalarials
(Katzung's Basic & Clinical Pharmacology, 16th ed.)
What is ACT (Artemisinin-Based Combination Therapy)?
ACT consists of an artemisinin derivative (fast-acting, short half-life) paired with a partner drug (slower-acting, longer half-life with a distinct mechanism of action).
The rationale:
- Artemisinins alone require >7 days of monotherapy to fully clear parasites
- When combined with an effective partner drug, a 3-day course is sufficient
- The partner drug eliminates the residual parasites remaining after the short artemisinin course
WHO-Recommended ACT Regimens
| ACT Regimen | Artemisinin Component | Partner Drug | Notes |
|---|---|---|---|
| Artemether-Lumefantrine (AL) (Coartem) | Artemether | Lumefantrine | Most widely used globally; 6-dose regimen over 3 days |
| Artesunate-Amodiaquine (AS-AQ) | Artesunate | Amodiaquine | Used in Africa |
| Artesunate-Mefloquine (AS-MQ) | Artesunate | Mefloquine | SE Asia (Thai-Myanmar border) |
| Artesunate-Sulfadoxine-Pyrimethamine (AS-SP) | Artesunate | Sulfadoxine-Pyrimethamine | India (national program) - used in non-NE states |
| Dihydroartemisinin-Piperaquine (DHA-PPQ) | Dihydroartemisinin | Piperaquine | SE Asia; longer piperaquine half-life allows once-daily dosing |
| Artesunate-Pyronaridine (AS-PY) (Pyramax) | Artesunate | Pyronaridine | Newer regimen |
India National Program ACT Regimens (Park's PSM)
For P. falciparum (non-NE states): ACT-SP
- Artesunate 4 mg/kg/day × 3 days
- Sulfadoxine-Pyrimethamine (25 mg/kg sulfadoxine) on Day 1
- Primaquine 0.75 mg/kg on Day 2 (gametocytocidal)
For P. falciparum (NE states): ACT-AL (Artemether-Lumefantrine)
- Due to SP resistance in North-Eastern India
Artemether-Lumefantrine (Coartem) dosing (adults):
- 4 tablets (each: artemether 20 mg + lumefantrine 120 mg) twice daily × 3 days
- With fatty food (enhances lumefantrine absorption)
Advantages of ACT Over Other Antimalarials
1. Rapid Parasite Clearance
Artemisinins act faster than any other antimalarial - they are active against ring-stage parasites (unique property) and reduce parasite biomass by ~10,000-fold per 48-hour cycle. They clear fever and parasitemia faster than chloroquine or quinine.
2. Activity Against Drug-Resistant Parasites
ACTs are effective against chloroquine-resistant, mefloquine-resistant, and SP-resistant P. falciparum - the major treatment failures seen with older monotherapies.
3. Reduced Risk of Resistance Development (Mutual Protection)
- The artemisinin component rapidly reduces parasite numbers to very low levels (~10³ parasites remain)
- The partner drug eliminates these residual parasites
- The probability of a parasite being simultaneously resistant to both components with different mechanisms is extremely low
- This mutual protection greatly delays the emergence of resistance to either drug
4. Gametocytocidal Effect - Reduced Transmission
Artemisinins reduce gametocyte carriage and are the only blood-stage drugs that kill immature gametocytes of P. falciparum (stages I-IV). This reduces onward transmission to mosquitoes - a public health advantage no older drug provides comparably.
5. Activity at Multiple Parasite Stages
Artemisinins are active against:
- Ring stage (unique - no other drug does this)
- Trophozoites
- Schizonts
- Immature gametocytes
This broad intra-erythrocytic coverage reduces the risk of treatment failure.
6. Short Treatment Course - Better Compliance
3-day ACT regimens vs. 7-day quinine + doxycycline regimen. Better patient adherence = more complete treatment.
7. Superior Efficacy in Severe Malaria
Parenteral artesunate (FDA-approved 2020) is superior to IV quinine in severe falciparum malaria - faster parasite clearance, fewer hypoglycemic episodes, lower mortality.
8. Safety Profile
Artemisinins are generally well-tolerated. Unlike:
- Chloroquine - retinopathy, cardiomyopathy with long-term use
- Quinine - cinchonism, hypoglycemia, cardiac arrhythmias
- Mefloquine - neuropsychiatric side effects
- SP - Stevens-Johnson syndrome, toxic epidermal necrolysis
9. No Cross-Resistance with Older Drugs
Artemisinins have a completely different mechanism (iron-activated free-radical generation from the endoperoxide bridge) compared to quinolines or antifolates, so prior exposure to older drugs does not confer resistance to artemisinins.
Summary: ACT vs Older Antimalarials at a Glance
| Feature | Chloroquine | Quinine | ACT |
|---|---|---|---|
| Speed of action | Moderate | Moderate | Very fast |
| Drug-resistant P. falciparum | Ineffective | Partially effective | Effective |
| Treatment duration | 3 days | 7 days | 3 days |
| Gametocytocidal | Partial | Partial | Yes (immature stages) |
| Resistance risk | Very high | Increasing | Low (with combination) |
| Side effects | Retinopathy, GI | Cinchonism, hypoglycemia | Well-tolerated |
| Severe malaria | No | IV quinine (2nd line) | IV artesunate (1st line) |
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics (Table 66-1, pp. 1309-1313); Katzung's Basic & Clinical Pharmacology, 16th ed. (pp. 1431-1433); Park's Textbook of Preventive & Social Medicine (pp. 308-309)
This is a shared conversation. Sign in to Orris to start your own chat.